A new $6 billion manufacturing facility owned by Eli Lilly and Company is now coming to Huntsville. The commitment reportedly represents the largest initial investment in Alabama's history and will create approximately 3,450 manufacturing and construction jobs on-site.

According to the multinational pharmaceutical corporation, the Huntsville location will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1 , orforglipron.

" Huntsville's track record of science and innovation, supported by advanced manufacturing expertise and a skilled workforce, makes Alabama an ideal location for Lilly to expand domestic manufacturing capacity for next‑generation medicines," said David A. Ricks , Lilly chair and CEO. "Today's investm

See Full Page